ÂÜÀòÂÒÂ×

Dr. Afshin Safavi is a veteran biochemist with extensive experience establishing and leading bioanalytical teams in pharmaceutical, biotechnology, and manufacturing companies, as well as contract research organizations. He is founder of BioAgilytix and is considered an expert in various immunoassay platforms and biomarker analysis.

Prior to founding BioAgilytix and acting as the Global Chief Scientific Officer, he was the Director of Ligand Binding and Immunoassay at AAIPharma. At Talecris BioTherapeutics he led the Preclinical and Clinical Assay Development team, building on his experience as a senior scientist at Nobex Corporation, GlaxoSmithKline and IGEN International. He obtained his BS in Biochemistry from UCLA, his PhD in Biochemistry from University of Kentucky Medical School and completed a two-year postdoctoral assignment at the Emory University Department of Pathology.